Ramipril boost for PAD patients

The off-patent ACE inhibitor ramipril doubles exercise tolerance in patients with intermittent claudication, an Australian randomised trial finds.

The research, published Wednesday in the Journal of the American Medical Association (online), found patients' exercise tolerance increased to an average of eight-and-a-half minutes following six months' of ramipril treatment, up from just four minutes at baseline.

By comparison, exercise